| |
| | Osteoporosis: OSIRIS validated for identifying bone-loss risk, July 1, 2004 (Site not responding. Last check: 2007-11-06) |
 | | Reginster and colleagues published their study in Gynecological Endocrinology (Validation of OSIRIS(R), a prescreening tool for the identification of women with an increased risk of osteoporosis. |
 | | For additional information, contact J.Y. Reginster, CHU Center Ville, Bone and Cartilage Metab Unit, Quai Godefroid Kurth 45, 9th Floor, B-4020 Liege, Belgium. |
 | | The publisher's contact information for the journal Gynecological Endocrinology is: Parthenon Publishing Group, Richmond House, White Cross, South Road, Lancaster LA1 4XQ, England. |
| www.obgyn.net /newsheadlines/womens_health-osteoporosis-20040701-110.asp (449 words) |
|